ONC

John Oyler

Known title: Chief Executive OfficerCIK: 0001042047

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BeOne Medicines Receives Rating Upgrade and Added to Top-Rated List. BeOne Medicines Ltd. has been upgraded to a top rating by analysts. It was also added to a list of top-rated stocks for the week. The upgrade follows recent earnings and infrastructure updates discussed in a broader market analysis. The move may influence investor perception of the company.

this person other insiders at ONC

Transaction History

ONC▼ Sell$702K
ONC▼ Sell$896K
ONC▼ Sell$5.5M
ONC▼ Sell$7.5M
ONC▼ Sell$5.1M
ONC▼ Sell$4.9M
ONC▼ Sell$2.9M
ONC▼ Sell$5.3M
ONC▼ Sell$4.2M
ONC▼ Sell$4.9M
ONC▼ Sell$1.9M
ONC▼ Sell$1.2M
ONC▼ Sell$440K
ONC▼ Sell$1K
ONC▼ Sell$23K
ONC▼ Sell$990K
ONC▼ Sell$1.3M
ONC▼ Sell$2.4M
ONC▼ Sell$1.2M
ONC▼ Sell$4.4M
ONC▼ Sell$5.7M
ONC▼ Sell$16.2M
ONC▼ Sell$7.6M
ONC▼ Sell$1.3M
ONC▼ Sell$4.9M
ONC▼ Sell$6.3M
ONC▼ Sell$2.5M
ONC▼ Sell$5.0M
ONC▼ Sell$749K
ONC▼ Sell$1.6M
ONC▼ Sell$1.9M
ONC▼ Sell$906K
ONC▲ Buy$4.1M
ONC▼ Sell$4.8M
ONC▼ Sell$4.5M
ONC▼ Sell$581K
ONC▼ Sell$477K
ONC▼ Sell$165K
ONC▼ Sell$89K
ONC▼ Sell$210K
ONC▼ Sell$1.5M
ONC▼ Sell$1.7M
ONC▼ Sell$11.2M
ONC▼ Sell$4.7M
ONC▼ Sell$183K
ONC▼ Sell$233K
ONC▼ Sell$16K
ONC▲ Buy$7.8M
ONC▼ Sell$439K
ONC▼ Sell$1.5M
ONC▼ Sell$3.0M
ONC▼ Sell$6.2M
ONC▼ Sell$10.2M
ONC▼ Sell$13.6M
ONC▼ Sell$2.0M
ONC▼ Sell$4.8M
ONC▼ Sell$503K
ONC▼ Sell$168K
ONC▲ Buy$15.5M
ONC▲ Buy$8.4M
ONC▼ Sell$73K
ONC▼ Sell$6.6M
ONC▼ Sell$4.2M
ONC▲ Buy$3.6M
ONC▲ Buy$13.0M
ONC▲ Buy$686K
ONC▼ Sell$1.9M
ONC▼ Sell$12.9M
ONC▼ Sell$4.0M
ONC▼ Sell$15.2M
ONC▼ Sell$2.4M
ONC▼ Sell$14.1M
ONC▼ Sell$2.5M
ONC▼ Sell$11.9M
ONC▼ Sell$12.5M
ONC▼ Sell$2.4M
ONC▼ Sell$1.3M
ONC▲ Buy$3.6M
ONC▲ Buy$3.6M
ONC▲ Buy$1.8M
ONC▼ Sell$241K
ONC▼ Sell$1.4M
ONC▼ Sell$8.0M
ONC▼ Sell$2.6M
ONC▼ Sell$259K
ONC▼ Sell$2.2M
ONC▼ Sell$98K
ONC▼ Sell$442K
ONC▲ Buy$432K
ONC▼ Sell$391K
ONC▼ Sell$917K
ONC▼ Sell$1.5M
ONC▼ Sell$111K
ONC▼ Sell$45K
ONC▼ Sell$41K
ONC▼ Sell$5K
ONC▼ Sell$492K
ONC▼ Sell$354K
ONC▼ Sell$88K
ONC▼ Sell$437K
ONC▼ Sell$455K
ONC▼ Sell$89K
ONC▲ Buy$0
ONC▼ Sell$190K
ONC▼ Sell$221K
ONC▼ Sell$52K
ONC▼ Sell$39K
ONC▼ Sell$304K
ONC▼ Sell$1.0M
ONC▲ Buy$0
ONC▲ Buy$0
ONC▼ Sell$565K
ONC▼ Sell$181K
ONC▼ Sell$775K
ONC▼ Sell$495K
ONC▼ Sell$601K
ONC▼ Sell$12K
ONC▼ Sell$2.3M
ONC▼ Sell$1.7M
ONC▼ Sell$382K
ONC▼ Sell$457K
ONC▼ Sell$38K
ONC▼ Sell$376K
ONC▼ Sell$291K
ONC▼ Sell$1.9M
ONC▼ Sell$1.5M
ONC▼ Sell$576K
ONC▼ Sell$540K
ONC▼ Sell$1.2M
ONC▼ Sell$1.8M
ONC▼ Sell$1.6M
ONC▼ Sell$4.4M
ONC▼ Sell$3.3M
ONC▼ Sell$5.1M
ONC▼ Sell$730K
ONC▼ Sell$0
ONC▼ Sell$0
ONC▼ Sell$1.3M
ONC▼ Sell$131K
ONC▼ Sell$4.1M
ONC▼ Sell$1.3M
ONC▼ Sell$2.2M
ONC▼ Sell$2.6M
ONC▼ Sell$396K
ONC▼ Sell$1.7M
ONC▼ Sell$2.4M
ONC▼ Sell$804K
ONC▼ Sell$26K
ONC▼ Sell$374K
ONC▼ Sell$979K
ONC▲ Buy$0
ONC▼ Sell$236K
ONC▼ Sell$351K
ONC▼ Sell$353K
ONC▼ Sell$253K
ONC▼ Sell$102K
ONC▲ Buy$2.0M
ONC▼ Sell$35.5M
ONC▼ Sell$173K
ONC▲ Buy$249K
ONC▲ Buy$268K
ONC▼ Sell$454K
ONC▼ Sell$1.6M
ONC▼ Sell$530K
ONC▼ Sell$1.7M
ONC▼ Sell$2.3M
ONC▼ Sell$1.3M
ONC▼ Sell$737K
ONC▼ Sell$1.2M
ONC▼ Sell$517K
ONC▼ Sell$2.2M
ONC▼ Sell$832K
ONC▼ Sell$279K
ONC▼ Sell$1.9M
ONC▼ Sell$3.1M
ONC▼ Sell$3.4M
ONC▼ Sell$577K
ONC▲ Buy$381K
ONC▼ Sell$330K
ONC▼ Sell$612K
ONC▼ Sell$344K
ONC▼ Sell$128K
ONC▼ Sell$294K
ONC▲ Buy$354K
ONC▲ Buy$243K
ONC▲ Buy$261K
ONC▼ Sell$3.5M
ONC▼ Sell$899K
ONC▼ Sell$2.1M
ONC▼ Sell$891K
ONC▼ Sell$26K
ONC▼ Sell$447K
ONC▼ Sell$1.7M
ONC▼ Sell$759K
ONC▲ Buy$0
ONC▼ Sell$150K
ONC▼ Sell$4.5M
ONC▲ Buy$610K
ONC▼ Sell$1.2M
ONC▲ Buy$657K

We use analytics to understand how market-wall is used. No personal data is sold.